Regarding the participants with MCI or AD, defined based on a clinical dementia rating (CDR) global score of 0.5 or 1, although the 18-month treatment with exenatide was safe and well-tolerated, it did not significantly affect clinical and cognitive measures, nor did it affect MRI cortical thickness and volume or most biomarkers in the cerebrospinal fluid (CSF), plasma, and plasma neuronal extracellular vesicles (EVs)
The tirzepatide weight loss timeline shows that most people begin seeing noticeable changes within the first four to six weeks
Ginger for treating nausea and vomiting: an overview of systematic reviews and meta-analyses
Other reported side effects include: a change in taste, muscle loss, and weight regain if the person stops using the drug
In situations where a high dose is needed, or where injection is the only option, the B12 shot is used